Who should receive oral antiviral therapy for severe acute respiratory syndrome coronavirus 2 infection in the omicron era? Choose wisely

Detalles Bibliográficos
Autor principal: Weiss, Guenter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728013/
https://www.ncbi.nlm.nih.gov/pubmed/36496153
http://dx.doi.org/10.1016/j.cmi.2022.11.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728013/
https://www.ncbi.nlm.nih.gov/pubmed/36496153
http://dx.doi.org/10.1016/j.cmi.2022.11.028

Ejemplares similares